Acadia

Drug makers leave the pain behind
Drug makers leave the pain behind
EP Vantage
painkillers
Acadia
Eli Lilly
Ampio Pharmaceuticals
Aptinyx
Eliem Therapeutics
Vertanical
Teva Pharamceutical
Regeneron
Vivozon
Vertex Pharmaceuticals
Biogen
Flag link:
Acadia, Neurocrine See Stock Price Bump After Quarterly Earnings
Acadia, Neurocrine See Stock Price Bump After Quarterly Earnings
Xconomy
earnings
Acadia
Neurocrine
Flag link:
Acadia drops after hours on Phase III miss for schizophrenia
Acadia drops after hours on Phase III miss for schizophrenia
BioCentury
Acadia
Nuplazid
schizophrenia
clinical trials
Flag link:
Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems
Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems
BioSpace
Acadia
FDA
Nuplazid
Parkinson's Disease Psychosis
Flag link:
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
CP Wire
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Parkinson's Disease Psychosis
Flag link:
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Flag link:
Acadia can’t shake off its Nuplazid nightmare
Acadia can’t shake off its Nuplazid nightmare
EP Vantage
Acadia
FDA
Nuplazid
antipsychotic
Flag link:
The 3 Worst Biotech Stocks of 2018 (So Far)
The 3 Worst Biotech Stocks of 2018 (So Far)
Motley Fool
biotech
Prothena
Tesaro
Acadia
Flag link:
FDA re-examines safety of controversial new drug Nuplazid
FDA re-examines safety of controversial new drug Nuplazid
CNN
FDA
Nuplazid
congress
Parkinson's Disease
Acadia
Flag link:
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
CP Wire
Acadia
Nuplazid
Parkinson's Disease Psychosis
Flag link:
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
Acadia
Nuplazid
Parkinson's Disease Psychosis
Flag link:
4 Biotechs Ready to Kill the Market in 2018
4 Biotechs Ready to Kill the Market in 2018
BIospace
biotech
Acadia
Sangamo Therapeutics
AnaptysBio
Sino Biopharmaceutical
Flag link:
Acadia launches Parkinson’s campaign to shine light on psychosis symptoms
Acadia launches Parkinson’s campaign to shine light on psychosis symptoms
Fierce Pharma
Acadia
Parkinson's Disease
Parkinson's Disease Psychosis
drug ads
Flag link:
AstraZeneca targeting California-based Acadia Pharmaceuticals ($4.4bn)
AstraZeneca targeting California-based Acadia Pharmaceuticals ($4.4bn)
GoInPharma
AstraZeneca
M&A
Acadia
Flag link:
Drugmakers turn to tech to better demonstrate empathy
Drugmakers turn to tech to better demonstrate empathy
Medical Marketing and Media
patients
physicians
empathy
Acadia
Flag link:
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Yahoo/Reuters
Acadia
Alzheimer's disease
pimavanserin
Flag link:
These 2 Biotechs Could Vanish by 2018
These 2 Biotechs Could Vanish by 2018
Motley Fool
biotech
Acadia
MannKind
Nuplazid
Afrezza
Flag link:
10 Must-Know Biotech Stock Events to Close Out 2016
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
Flag link:
3 Biotech Stocks With Explosive Upside Potential
3 Biotech Stocks With Explosive Upside Potential
Motley Fool
Acadia
Nuplazid
Radius Health
abaloparatide-SC
Sarepta Therapeutics
eteplirsen
Flag link:
These 3 Biotechs Have Automatic Demand
These 3 Biotechs Have Automatic Demand
Motley Fool
biotech
Acadia
Portola Pharmaceuticals
Ophthotech
Flag link:

Pages